CD8A and neoplasm: In clinical studies, the combination of faecal microbial transplantation (FMT) and anti‐PD‐1 therapy activated mucosa‐associated invariant T cells (MAIT) and CD56+ CD8+ T cells in peripheral blood mononuclear cells (PBMCs), resulting in increased activation of CD8+ T cells at tumour sites.66